KBC Group’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-63,851
Closed -$958K 1324
2021
Q4
$958K Hold
63,851
﹤0.01% 727
2021
Q3
$1.67M Sell
63,851
-62,435
-49% -$2.3M 0.01% 688
2021
Q2
$6.31M Buy
126,286
+4,524
+4% +$202K 0.01% 578
2021
Q1
$5.61M Sell
121,762
-136,182
-53% -$6.5M 0.01% 589
2020
Q4
$60.8M Buy
257,944
+90,160
+54% +$3.42M 0.03% 447
2020
Q3
$6.84M Buy
167,784
+73,724
+78% +$3.67M 0.02% 486
2020
Q2
$5.15M Buy
94,060
+50,003
+113% +$2.86M 0.02% 511
2020
Q1
$2.3M Sell
44,057
-151,685
-77% -$8.21M 0.02% 510
2019
Q4
$9.53M Buy
195,742
+116,823
+148% +$5.47M 0.06% 335
2019
Q3
$4.33M Sell
78,919
-4,219
-5% -$241K 0.03% 473
2019
Q2
$4.15M Sell
83,138
-5,933
-7% -$295K 0.03% 469
2019
Q1
$5.03M Buy
+89,071
New +$5.31M 0.04% 418
2018
Q4
Sell
-5,339
Closed -$433K 1389
2018
Q3
$433K Sell
5,339
-150,233
-97% -$11M ﹤0.01% 1139
2018
Q2
$9.93M Buy
+155,572
New +$7.63M 0.09% 285

Other funds holding TRHC

KBC Group's TRHC Position: Q1 2022 in Review

KBC Group sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q1 2022, closing a stake of 63,851 shares — an estimated $958K sold.

KBC Group first reported a position in TRHC in Q2 2018 and held it in 14 quarters. The position peaked at $60.8M in Q4 2020. 139 funds tracked by Wall St. Rank hold TRHC as of Q1 2022.

  • KBC Group reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • KBC Group sold 63,851 Tabula Rasa HealthCare, Inc. Common Stock shares in Q1 2022, an estimated $958K.
  • KBC Group first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q2 2018 and held it in 14 quarters.
  • KBC Group's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $60.8M in Q4 2020.
  • 139 funds tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q1 2022.

Based on KBC Group's 13F filing for Q1 2022, filed 6 May 2022.